Modified Renshen Yangrong decoction enhances angiogenesis in ischemic stroke through promotion of MicroRNA‐210 expression by regulating the HIF/VEGF/Notch signaling pathway

Ce Liang,Teng Zhang,Xu‐Liang Shi,Lin Jia,Ya‐Li Wang,Cui‐Huan Yan
DOI: https://doi.org/10.1002/brb3.2295
IF: 3.1
2021-08-01
Brain and Behavior
Abstract:ObjectiveThis study aims to investigate the efficacy of modified Ginseng Yangrong decoction (GSYRD) promoting angiogenesis after ischemic stroke. MethodsIn an in vivo study, rats that survived surgery were allocated into four groups: the control group and model group were treated with normal saline, the GSYRD group was treated with 18.9 mg/kg of GSYRD daily, and the positive control group was treated with Tongxinluo (TXL) (1 g/kg/d). At the end of the seven-day treatment, the area of cerebral infarction, the expression changes of miRNA-210 and ephrin A3 were determined. In an in vitro study, HUVECs were divided into a normal control serum group (NC group), normal control serum OGD group (Oxygen Glucose Deprivation group) (OGD group), OGD + drug-containing serum group (OGD+GSYRD group), and OGD + drug-containing serum + ES group (Endostatin group) (OGD+GSYRD+ES group). The cells in all groups except the NC group were cultured in a sugar-free DMEM medium under hypoxia for 48 h. Cell proliferation, angiogenic structure formation ability, the expression changes of miRNA-210, ephrin A3, and the HIF/VEGF/Notch signaling pathway-related molecules were determined. ResultsIn vivo, GSYRD significantly reduced infarct size (p < .01), the expression of miRNA-210 and ephrin A3 were decreased in the GSYRD group (p < .05). In vitro, the cell proliferation and tube formation ability were significantly increased in the GSYRD group (p < .05), and the expression of miRNA-210 and ephrin A3 was decreased (p < .05). In addition, in the GSYRD group, the expression of the HIF/VEGF/Notch signaling pathway-related molecules was significantly increased (p < .01 or p < .05). ConclusionGSYRD promotes cerebral protection following angiogenesis and ischemic brain injury. The specific mechanism was activating the HIF/VEGF/Notch signaling pathway via miRNA-210.
behavioral sciences,neurosciences
What problem does this paper attempt to address?
This paper primarily explores the role and molecular mechanisms of the modified Ginseng Yangrong Decoction (GSYRD) in promoting angiogenesis after ischemic stroke. ### Research Objectives - **Primary Objective**: To study the effect of the modified Ginseng Yangrong Decoction (GSYRD) on promoting angiogenesis after ischemic stroke. - **Specific Objectives**: - To investigate the effect of GSYRD on the infarct size in rats with ischemic stroke. - To analyze the impact of GSYRD on the expression of microRNA-210. - To explore the specific mechanisms by which GSYRD promotes angiogenesis through the regulation of the HIF/VEGF/Notch signaling pathway. ### Overview of Research Methods - **Animal Experiments**: A rat model of ischemic stroke was established, and the rats were divided into control group, model group, GSYRD treatment group, and positive control group (using Tongxinluo). - **Cell Experiments**: Human umbilical vein endothelial cells (HUVECs) were used for in vitro experiments to study the effects of GSYRD on cell proliferation, tubular structure formation, and the expression of related molecules. - **Exploration of Molecular Mechanisms**: The mechanism of GSYRD was explored by detecting changes in the expression of miRNA-210 and its target gene ephrin A3, as well as the expression levels of molecules related to the HIF/VEGF/Notch signaling pathway. ### Main Findings - **In Vivo Studies**: GSYRD significantly reduced the infarct size and decreased the expression of miRNA-210 and ephrin A3. - **In Vitro Studies**: GSYRD enhanced the proliferation and tubular structure formation abilities of HUVECs and reduced the expression of miRNA-210 and ephrin A3. - **Molecular Mechanisms**: GSYRD activated the HIF/VEGF/Notch signaling pathway, thereby promoting angiogenesis. In summary, this study aims to verify the angiogenic effect of the modified Ginseng Yangrong Decoction in the treatment of ischemic stroke and to reveal the specific mechanisms by which it achieves this effect through the regulation of the HIF/VEGF/Notch signaling pathway and miRNA-210.